Let’s start up with the current stock price of Acasti Pharma Inc. (ACST), which is $2.20 to be very precise. The Stock rose vividly during the last session to $2.41 after opening rate of $2.41 while the lowest price it went was recorded $2.18 before closing at $2.45.Recently in News on September 14, 2021, Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ. Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer Fall Healthcare Summit being held virtually September 20-23, 2021. You can read further details here
Acasti Pharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.76 on 02/10/21, with the lowest value was $2.16 for the same time period, recorded on 09/08/21.
Acasti Pharma Inc. (ACST) full year performance was 39.95%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Acasti Pharma Inc. shares are logging -77.46% during the 52-week period from high price, and 60.82% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.37 and $9.76.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1382915 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Acasti Pharma Inc. (ACST) recorded performance in the market was -15.38%, having the revenues showcasing -47.62% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 118.65M, as it employees total of 32 workers.
Market experts do have their say about Acasti Pharma Inc. (ACST)
During the last month, 0 analysts gave the Acasti Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.81, with a change in the price was noted -1.48. In a similar fashion, Acasti Pharma Inc. posted a movement of -40.22% for the period of last 100 days, recording 1,455,375 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ACST is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Acasti Pharma Inc. (ACST)
Raw Stochastic average of Acasti Pharma Inc. in the period of last 50 days is set at 1.62%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.36%. In the last 20 days, the company’s Stochastic %K was 10.03% and its Stochastic %D was recorded 9.18%.
Bearing in mind the latest performance of Acasti Pharma Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.38%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -61.54%, alongside a boost of 39.95% for the period of the last 12 months. The shares increased approximately by -2.65% in the 7-day charts and went up by -38.86% in the period of the last 30 days. Common stock shares were lifted by -47.62% during last recorded quarter.